Clinical Benefits of Actovegin
Actovegin is a deproteinized hemoderivative extracted from calf blood. It is clinically used to support tissue regeneration, promote microcirculation, and treat conditions associated with impaired perfusion such as diabetic ulcers, surgical wounds, and neurological dysfunctions.
1. Accelerated Wound Healing
Actovegin enhances oxygen and glucose uptake in cells, stimulating cellular metabolism and accelerating wound closure. In clinical trials, topical and injectable Actovegin has demonstrated significantly faster healing rates post-surgery and in traumatic injuries.
2. Ulcer Treatment in Diabetic Patients
Studies involving patients with chronic diabetic ulcers show that Actovegin improves tissue granulation, reduces ulcer size, and shortens healing time when compared to standard treatments. It is frequently included in advanced wound care protocols.
3. Enhanced Microcirculation
Actovegin supports capillary perfusion and endothelial function. In patients with Raynaud’s phenomenon, administration of Actovegin reduced vasospastic symptoms and improved peripheral blood flow, thereby restoring tissue oxygenation.
4. Support for Cognitive Function
Clinical studies on patients with vascular dementia report improved cognitive outcomes after parenteral administration of Actovegin. Memory, attention, and social functioning showed measurable improvement, with ongoing research into its role in Alzheimer’s therapy.